Genetic testing firm 23andMe files for bankruptcy, facing potential delisting from NASDAQ.

23andMe, a genetic testing company, has filed for bankruptcy amid financial distress, potentially leading to its delisting from NASDAQ. California Attorney General Rob Bonta reminded users of their right to request the permanent deletion of their genetic data under state laws. Customers can delete their account and request the destruction of their DNA samples and data by following the steps on the 23andMe website.